Advertisement
Screener

REZOLUTE, INC. (RZLT) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

REZOLUTE, INC. Operating Cash Flow

REZOLUTE, INC. (RZLT) reported Operating Cash Flow of -$64.64 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-24.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-09-24

  • REZOLUTE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$13.15M.
  • REZOLUTE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$13.73M.
  • REZOLUTE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$20.32M.
  • REZOLUTE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$17.43M.
  • REZOLUTE, INC. net cash provided by (used in) operating activities for fiscal 2026 was -$64.64M.
  • REZOLUTE, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$69.08M.
  • REZOLUTE, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$57.37M.
  • REZOLUTE, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$44.48M.
Period endNet Cash Provided by (Used in) Operating Activities 2 monthNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 5 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 8 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 11 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filedNet Cash Provided by (Used in) Operating Activities 14 monthNet Cash Provided by (Used in) Operating Activities 17 monthNet Cash Provided by (Used in) Operating Activities 20 monthNet Cash Provided by (Used in) Operating Activities 26 monthNet Cash Provided by (Used in) Operating Activities 29 monthNet Cash Provided by (Used in) Operating Activities 36 monthNet Cash Provided by (Used in) Operating Activities 39 monthNet Cash Provided by (Used in) Operating Activities 42 monthNet Cash Provided by (Used in) Operating Activities 45 monthNet Cash Provided by (Used in) Operating Activities 48 month
2026-06-30-$13.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-24
-$26.88M
derived: sum of 2 quarters · filed 2026-09-24
-$47.20M
derived: sum of 3 quarters · filed 2026-09-24
-$64.64M
10-K · filed 2026-09-24
2026-03-31-$13.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12
-$34.06M
derived: sum of 2 quarters · filed 2026-05-12
-$51.49M
10-Q · filed 2026-05-12
-$73.48M
derived: sum of 4 quarters · filed 2026-09-24
2025-12-31-$20.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12
-$37.75M
10-Q · filed 2026-02-12
-$59.75M
derived: sum of 3 quarters · filed 2026-09-24
-$77.15M
derived: sum of 4 quarters · filed 2026-09-24
2025-09-30-$17.43M
10-Q · filed 2025-11-06
-$39.42M
derived: sum of 2 quarters · filed 2026-09-24
-$56.83M
derived: sum of 3 quarters · filed 2026-09-24
-$70.49M
derived: sum of 4 quarters · filed 2026-09-24
2025-06-30-$22.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-24
-$39.40M
derived: sum of 2 quarters · filed 2026-09-24
-$53.06M
derived: sum of 3 quarters · filed 2026-09-24
-$69.08M
10-K · filed 2026-09-24
2025-03-31-$17.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12
-$31.07M
derived: sum of 2 quarters · filed 2026-05-12
-$47.08M
10-Q · filed 2026-05-12
-$65.60M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31-$13.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12
-$29.68M
10-Q · filed 2026-02-12
-$48.20M
derived: sum of 3 quarters · filed 2026-02-12
-$63.44M
derived: sum of 4 quarters · filed 2026-02-12
2024-09-30-$16.01M
10-Q · filed 2025-11-06
-$34.54M
derived: sum of 2 quarters · filed 2025-11-06
-$49.78M
derived: sum of 3 quarters · filed 2025-11-06
-$62.80M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$18.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-17
-$33.76M
derived: sum of 2 quarters · filed 2025-09-17
-$46.78M
derived: sum of 3 quarters · filed 2025-09-17
-$57.37M
10-K · filed 2025-09-17
2024-03-31-$15.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13
-$28.26M
derived: sum of 2 quarters · filed 2025-05-13
-$38.85M
10-Q · filed 2025-05-13
-$50.20M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$13.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-12
-$23.61M
10-Q · filed 2025-02-12
-$34.95M
derived: sum of 3 quarters · filed 2025-02-12
-$53.00M
derived: sum of 4 quarters · filed 2025-02-12
2023-09-30-$10.59M
10-Q · filed 2024-11-07
-$21.93M
derived: sum of 2 quarters · filed 2024-11-07
-$39.98M
derived: sum of 3 quarters · filed 2024-11-07
-$47.48M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$11.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19
-$29.40M
derived: sum of 2 quarters · filed 2024-09-19
-$36.89M
derived: sum of 3 quarters · filed 2024-09-19
-$44.48M
10-K · filed 2024-09-19
2023-03-31-$18.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15
-$25.54M
derived: sum of 2 quarters · filed 2024-05-15
-$33.13M
10-Q · filed 2024-05-15
-$45.24M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$7.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13
-$15.08M
10-Q · filed 2024-02-13
-$27.19M
derived: sum of 3 quarters · filed 2024-02-13
-$41.16M
derived: sum of 4 quarters · filed 2024-02-13
2022-09-30-$7.59M
10-Q · filed 2023-11-13
-$19.70M
derived: sum of 2 quarters · filed 2023-11-13
-$33.67M
derived: sum of 3 quarters · filed 2023-11-13
-$40.86M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30-$12.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-14
-$26.08M
derived: sum of 2 quarters · filed 2023-09-14
-$33.27M
derived: sum of 3 quarters · filed 2023-09-14
-$39.62M
10-K · filed 2023-09-14
2022-03-31-$13.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11
-$21.16M
derived: sum of 2 quarters · filed 2023-05-11
-$27.51M
10-Q · filed 2023-05-11
-$32.74M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$7.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-10
-$13.54M
10-Q · filed 2023-02-10
-$18.77M
derived: sum of 3 quarters · filed 2023-02-10
-$24.16M
derived: sum of 4 quarters · filed 2023-02-10
2021-09-30-$6.34M
10-Q · filed 2022-11-09
-$11.57M
derived: sum of 2 quarters · filed 2022-11-09
-$16.97M
derived: sum of 3 quarters · filed 2022-11-09
-$23.23M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30-$5.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-15
-$10.63M
derived: sum of 2 quarters · filed 2022-09-15
-$16.89M
derived: sum of 3 quarters · filed 2022-09-15
-$20.44M
10-K · filed 2022-09-15
2021-03-31-$5.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-12
-$11.66M
derived: sum of 2 quarters · filed 2022-05-12
-$15.21M
10-Q · filed 2022-05-12
-$19.29M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$6.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-09
-$9.81M
10-Q · filed 2022-02-09
-$13.89M
derived: sum of 3 quarters · filed 2022-02-09
-$19.57M
derived: sum of 4 quarters · filed 2022-02-09
2020-09-30-$3.55M
10-Q · filed 2021-11-12
-$7.63M
derived: sum of 2 quarters · filed 2021-11-12
-$13.31M
derived: sum of 3 quarters · filed 2021-11-12
-$18.79M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$4.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-15
-$9.76M
derived: sum of 2 quarters · filed 2021-09-15
-$15.24M
derived: sum of 3 quarters · filed 2021-09-15
-$24.17M
10-K · filed 2021-09-15
2020-03-31-$5.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17
-$11.16M
derived: sum of 2 quarters · filed 2021-05-17
-$20.09M
10-Q · filed 2021-05-17
-$23.86M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$5.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-10
-$14.41M
10-Q · filed 2021-02-10
-$18.18M
derived: sum of 3 quarters · filed 2021-02-10
-$26.63M
derived: sum of 4 quarters · filed 2021-02-10
2019-09-30-$8.93M
10-Q · filed 2020-11-12
-$12.69M
derived: sum of 2 quarters · filed 2020-11-12
-$21.15M
derived: sum of 3 quarters · filed 2020-11-12
-$22.80M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30-$3.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13
-$12.22M
derived: sum of 2 quarters · filed 2020-10-13
-$13.87M
derived: sum of 3 quarters · filed 2020-10-13
-$15.30M
10-K · filed 2020-10-13
2019-03-31-$8.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-14
-$10.11M
derived: sum of 2 quarters · filed 2020-05-14
-$11.54M
10-Q · filed 2020-05-14
-$11.54M
10-Q · filed 2019-05-10
-$15.42M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31-$1.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-12
-$3.08M
10-Q · filed 2020-02-12
-$3.08M
10-Q · filed 2019-02-14
-$6.97M
derived: sum of 3 quarters · filed 2020-02-12
-$9.14M
derived: sum of 4 quarters · filed 2020-02-12
2018-09-30-$1.43M
10-Q · filed 2019-11-14
-$1.43M
10-Q · filed 2018-12-14
-$5.31M
derived: sum of 2 quarters · filed 2019-11-14
-$7.49M
derived: sum of 3 quarters · filed 2019-11-14
-$10.64M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30-$3.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-10
-$6.06M
derived: sum of 2 quarters · filed 2019-09-10
-$9.21M
derived: sum of 3 quarters · filed 2019-09-10
-$14.11M
10-K · filed 2019-09-10
-$14.11M
10-K · filed 2018-10-15
2018-03-31-$2.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10
-$5.33M
derived: sum of 2 quarters · filed 2019-05-10
-$10.23M
10-Q · filed 2019-05-10
-$13.87M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31-$3.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14
-$8.05M
10-Q · filed 2019-02-14
-$11.70M
derived: sum of 3 quarters · filed 2019-02-14
-$15.31M
derived: sum of 4 quarters · filed 2019-02-14
2017-09-30-$4.91M
10-Q · filed 2018-12-14
-$8.55M
derived: sum of 2 quarters · filed 2018-12-14
-$12.16M
derived: sum of 3 quarters · filed 2018-12-14
-$15.25M
derived: sum of 4 quarters · filed 2018-12-14
2017-06-30-$3.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-15
-$7.25M
derived: sum of 2 quarters · filed 2018-10-15
-$10.34M
derived: sum of 3 quarters · filed 2018-10-15
-$13.31M
10-K · filed 2018-10-15
2017-03-31-$3.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-15
-$6.70M
derived: sum of 2 quarters · filed 2018-05-15
-$9.67M
10-Q · filed 2018-05-15
2016-12-31-$3.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14
-$6.06M
10-Q · filed 2018-02-14
2016-09-30-$2.97M
10-Q · filed 2017-11-14
2014-03-31-$707.58K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-14
-$1.07M
derived: sum of 2 quarters · filed 2014-05-14
-$1.07M
10-Q · filed 2014-05-14
-$1.30M
derived: sum of 4 quarters · filed 2014-05-14
-$3.59M
10-Q · filed 2014-05-14
2013-12-31-$365.27K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-13
-$361.60K
10-Q · filed 2014-02-13
-$594.34K
derived: sum of 3 quarters · filed 2014-02-13
-$1.25M
derived: sum of 4 quarters · filed 2014-05-14
-$2.89M
10-Q · filed 2014-02-13
2013-09-30$3.67K
10-Q · filed 2013-11-12
-$229.07K
derived: sum of 2 quarters · filed 2013-11-12
-$880.75K
derived: sum of 3 quarters · filed 2014-05-14
-$1.28M
derived: sum of 4 quarters · filed 2014-05-14
-$2.52M
10-Q · filed 2013-11-12
2013-06-30-$232.74K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11
-$884.42K
derived: sum of 2 quarters · filed 2014-05-14
-$1.28M
derived: sum of 3 quarters · filed 2014-05-14
-$1.63M
10-K · filed 2013-09-11
-$2.52M
10-K · filed 2013-09-11
2013-03-31-$651.67K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-14
-$1.05M
derived: sum of 2 quarters · filed 2014-05-14
-$1.40M
10-Q · filed 2014-05-14
-$973.79K
derived: sum of 4 quarters · filed 2014-05-14
-$2.38M
10-Q · filed 2013-05-15
2012-12-31-$398.51K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-13
-$743.55K
10-Q · filed 2014-02-13
-$21.00K
10-Q · filed 2013-02-14
-$322.11K
derived: sum of 3 quarters · filed 2014-02-13
-$762.76K
derived: sum of 4 quarters · filed 2014-02-13
-$66.17K
10-Q · filed 2013-02-14
2012-09-30-$345.04K
10-Q · filed 2013-11-12
-$4.65K
10-Q · filed 2012-11-19
$76.40K
derived: sum of 2 quarters · filed 2013-11-12
-$364.25K
derived: sum of 3 quarters · filed 2013-11-12
-$371.88K
derived: sum of 4 quarters · filed 2013-11-12
-$49.82K
10-Q · filed 2012-11-19
2012-06-30$421.44K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-11-09
-$285.38K
10-K · filed 2013-09-11
-$26.85K
derived: sum of 3 quarters · filed 2013-05-15
-$45.17K
10-K/A · filed 2012-11-09
-$40.40K
10-K/A · filed 2012-11-09
2012-03-31-$440.65K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15
-$448.28K
derived: sum of 2 quarters · filed 2013-05-15
-$461.83K
10-Q · filed 2013-05-15
-$28.09K
10-Q · filed 2012-05-15
-$32.86K
10-Q · filed 2012-05-15
2011-12-31-$7.63K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14
-$21.18K
10-Q · filed 2013-02-14
-$363.22K
10-K · filed 2013-09-11
-$25.95K
10-Q · filed 2012-02-14
2011-09-30-$13.55K
10-Q · filed 2012-11-19
-$18.32K
10-Q/A · filed 2011-12-13
2011-06-30-$4.77K
10-K/A · filed 2012-11-09
2011-03-31-$1.25K
10-Q · filed 2012-05-15
2010-12-31-$1.25K
10-Q · filed 2012-02-14
2010-09-30-$25.00K
10-Q/A · filed 2011-12-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Vogenx, Inc. (VOGX)United States$0.355B
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43